SEMNL, headquartered in Beijing, is committed to the R&D, production and sales of bioactive peptide with biotechnology at the core. It is a high-tech enterprise recognized by the municipality of Beijing and the state, and has set up three major marketing and service centers in Beijing, Shanghai and Guangzhou. SEMNL lands the Bioactive Peptide Health Research Institute in cooperation with the Institute of Process Engineering, Chinese Academy of Sciences (CAS), and the bioactive-peptide production base in Huaibei, Anhui Province. So far, its product portfolio includes collagen peptide, SEMFLEX-II undenatured type II collagen, type III collagen peptide, PGXR oligopeptide, SEMPEP-II hydrolyzed type II collagen,oyster extract, elastin peptide, collagen tripeptide and so on.